Lupin Recalls Irbesartan & Hydrochlorothiazide/Irbesartan Tablets

The voluntary nationwide recall was prompted by a possible impurity and affects all batches of the antihypertensive tablets.

Related Keywords

,Drug Administration Safety Information ,Twitter ,Facebook ,Drug Administration ,Lupin Pharmaceuticals ,Safety Information ,Adverse Event Reporting ,Patrice Wendling ,Medscape Cardiology ,Hypertension ,Increased Blood Pressure ,Diabetes Mellitus ,Chronic Renal Failure ,Hronic Kidney Failure ,Hronic Kidney Disease Ckd ,Chronic Kidney Disease ,Kd ,Angiotensin Ii Receptor Blockade ,Antihypertensive ,Proteinuria ,Adverse Effects ,Side Effects ,Carcinogen ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Patient Safety ,Diabetes Mellitus Type 2 ,Iabetes Mel ,